VMA21
Vacuolar ATPase assembly integral membrane protein VMA21
Also known as: MEAX, VMA21_HUMAN, XMEA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3ZAQ7
- Gene
- VMA21
- Ensembl
- ENSG00000160131
- Chromosome
- X
- Canonical length
- 101 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a chaperone for assembly of lysosomal vacuolar ATPase.[provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
101 residues, UniProt reviewed canonical sequence.
>Q3ZAQ7|VMA21
1 MERPDKAALN ALQPPEFRNE SSLASTLKTL LFFTALMITV PIGLYFTTKS YIFEGALGMS
61 NRDSYFYAAI VAVVAVHVVL ALFVYVAWNE GSRQWREGKQ DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VMA21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 22 nTPM
- hypothalamus: 19 nTPM
- cerebral cortex: 17 nTPM
- midbrain: 15 nTPM
- retina: 15 nTPM
- hippocampal formation: 14 nTPM
Single-cell type
- kupffer cells: 169 nCPM
- hofbauer cells: 161 nCPM
- monocytes: 101 nCPM
- monocyte progenitors: 97 nCPM
- gastric progenitor cells: 87 nCPM
- extravillous trophoblasts: 83 nCPM
Immune cell
- intermediate monocyte: 14 nTPM
- myeloid DC: 14 nTPM
- non-classical monocyte: 13 nTPM
- NK-cell: 13 nTPM
- classical monocyte: 12 nTPM
- plasmacytoid DC: 12 nTPM
Brain region
- hypothalamus: 45 nTPM
- midbrain: 40 nTPM
- pons: 39 nTPM
- medulla oblongata: 38 nTPM
- spinal cord: 38 nTPM
- white matter: 36 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about VMA21.
Disease | AllUniProt
Conditions VMA21 is implicated in, by any mechanism.
- Myopathy, X-linked, with excessive autophagy (MEAX) MIM:310440
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 118 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- X-linked myopathy with excessive autophagy
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 0.78
- DepMap mean gene effect
- -0.36
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Vacuolar ATPase assembly integral membrane protein Vma21
- VMA21-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VMA21 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VMA21 as an antibody target. Whether an autoantibody or antibody against VMA21 could matter depends on whether native VMA21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VMA21 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label VMA21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...